• Northumbria University Featured PhD Programmes
  • University of Warwick Featured PhD Programmes
  • University of East Anglia Featured PhD Programmes
  • National University of Singapore Featured PhD Programmes
  • University College London Featured PhD Programmes
  • University of Leeds Featured PhD Programmes
  • University of Glasgow Featured PhD Programmes
University of York Featured PhD Programmes
Imperial College London Featured PhD Programmes
University of the West of England, Bristol Featured PhD Programmes
University of Southampton Featured PhD Programmes
University of Reading Featured PhD Programmes

Novel Approaches to the Emergency Management of Hyperkalaemia

  • Full or part time
  • Application Deadline
    Sunday, March 04, 2018
  • Competition Funded PhD Project (European/UK Students Only)
    Competition Funded PhD Project (European/UK Students Only)

Project Description

As part of the Experimental Medicine Training Initiative, this is a prestigious fully-funded, clinical PhD Studentship at the University of Cambridge. This innovative initiative is a partnership between the University of Cambridge, Cambridge Biomedical Research Centre and Pharmaceutical Companies. The Studentship is available from April 2018, and provides an unrivalled opportunity to undertake high quality clinical research in the area of nephrology and clinical pharmacology, in collaboration with AstraZeneca. It will appeal to clinical trainees from a wide range of disciplines including Clinical Pharmacology, Nephrology and Acute Medicine. The Studentship award will cover a clinical stipend for 3 years, University and College fees, and a generous training allowance.

This project is a unique opportunity to join a collaboration between the Division of Experimental Medicine and Immunotherapeutics at the University of Cambridge, and the Renal division at AstraZeneca.
The remit will be to study the epidemiology, sequelae and treatment of hyperkalaemia with particular reference to the emergency setting. Existing treatments have important limitations. Novel treatment options exist, and the studentship will be focused on the design and conduct of epidemiological, physiological and proof of concept studies to develop novel approaches to the emergency management of hyperkalaemia.
Working closely with leading investigators in the Division of Experimental Medicine and Immunotherapeutics from the University of Cambridge, the Cambridge Clinical Trials Unit and AstraZeneca, you will apply the findings of these studies to the design of a late phase emergency medicine trial.
This project will provide you with an opportunity to apply your strengths to emergency, renal and experimental medicine, and will provide a unique hands-on perspective of translational medicine. The successful applicant will be offered the opportunity to spend time with AstraZeneca and international academic collaborators. The structured mentoring and training environment will allow the candidate to develop as an academic clinician with expertise in designing and conducting experimental medicine studies and later phase trials.

Funding Notes

The Studentship award will cover a clinical stipend for 3 years, University and College fees, and a generous training allowance

References

Two

How good is research at University of Cambridge in Clinical Medicine?

FTE Category A staff submitted: 192.05

Research output data provided by the Research Excellence Framework (REF)

Click here to see the results for all UK universities

Email Now

Insert previous message below for editing? 
You haven’t included a message. Providing a specific message means universities will take your enquiry more seriously and helps them provide the information you need.
Why not add a message here
* required field
Send a copy to me for my own records.

Your enquiry has been emailed successfully




Cookie Policy    X